Blackstone Group Inc (BX)vsHelius Medical Technologies Inc Class A (HSDT)
BX
Blackstone Group Inc
$128.51
+2.47%
FINANCIAL SERVICES · Cap: $149.90B
HSDT
Helius Medical Technologies Inc Class A
$2.22
+3.26%
FINANCIAL SERVICES · Cap: $125.75M
Smart Verdict
WallStSmart Research — data-driven comparison
Blackstone Group Inc generates 128158% more annual revenue ($15.48B vs $12.07M). BX leads profitability with a 22.7% profit margin vs 0.0%. HSDT trades at a lower P/E of 0.0x. BX earns a higher WallStSmart Score of 75/100 (B+).
BX
Strong Buy75
out of 100
Grade: B+
HSDT
Avoid34
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 39 in profit
Strong operational efficiency at 54.4%
Earnings expanding 57.3% YoY
Large-cap with strong market position
Keeps 23 of every $100 in revenue as profit
Revenue surging 28.6% year-over-year
Attractively priced relative to earnings
Reasonable price relative to book value
Revenue surging 5774.0% year-over-year
Safe zone — low bankruptcy risk
Areas to Watch
Moderate valuation
Trading at 11.4x book value
Elevated debt levels
Weak financial health signals
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -137.4% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : BX
The strongest argument for BX centers on Return on Equity, Operating Margin, EPS Growth. Profitability is solid with margins at 22.7% and operating margin at 54.4%. Revenue growth of 28.6% demonstrates continued momentum.
Bull Case : HSDT
The strongest argument for HSDT centers on P/E Ratio, Price/Book, Revenue Growth. Revenue growth of 5774.0% demonstrates continued momentum.
Bear Case : BX
The primary concerns for BX are P/E Ratio, Price/Book, Debt/Equity. Debt-to-equity of 1.56 is elevated, increasing financial risk.
Bear Case : HSDT
The primary concerns for HSDT are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
BX profiles as a growth stock while HSDT is a hypergrowth play — different risk/reward profiles.
BX carries more volatility with a beta of 1.56 — expect wider price swings.
HSDT is growing revenue faster at 5774.0% — sustainability is the question.
BX generates stronger free cash flow (1.9B), providing more financial flexibility.
Bottom Line
BX scores higher overall (75/100 vs 34/100), backed by strong 22.7% margins and 28.6% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Blackstone Group Inc
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Blackstone Group Inc. is an alternative asset management company specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity strategies and multiple asset classes. The company is headquartered in New York, New York with additional offices across Asia, Europe and North America.
Helius Medical Technologies Inc Class A
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing and acquiring non-invasive technologies for the treatment of symptoms caused by neurological diseases or trauma. The company is headquartered in Newtown, Pennsylvania.
Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?